CliffBio
small molecule

DEXTROSE 60% IN PLASTIC CONTAINER

DEXTROSE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameDEXTROSE 60% IN PLASTIC CONTAINER
Active ingredientDEXTROSE
Strength60GM/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJuly 1991
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.